Allergic Rhinitis Market is expected to grow by the CAGR of 7% by 2023
Global Allergic Rhinitis Market; by Type (Seasonal, Perennial and Non allergic rhinitis), by Treatment (Antihistamines, Decongestants, Eye drops, Nasal sprays and others) and by Test (Skin Test, IgE RAST Test and Complete Blood Count) – Forecast to 2023
Pune, India – June 23, 2017 /MarketersMedia/ —
Market Highlights
Hay fever is another name for allergic rhinitis which is a nose related disease. This fever affects nose first and clogs it. The cause of this is due to allergens to which the affected person is highly exposed to. Other parts of the body affected due to hay fever include ears, eye and throat and they are mostly affected due to blocked nose. There are various products available to treat problems arising due to allergic rhinitis. Every second a person is affected by cold and cough. Medicines available to treat allergic rhinitis are available in almost every chemist shop. The sale for anti-allergic rhinitis is increasing and is expected to increase further in future as well.
Global Allergic Rhinitis market Players:
• Merck (US),
• GSK (UK),
• Sanofi (France),
• Cigna (USA),
• Himalaya (India),
• J&J (US),
• Chong kun Dang Pharmaceutical Corp. (South Korea),
• Faes, Farma (Spain),
• Glenmark Pharmaceutical (India),
• Hisamitsu Pharmaceutical Co.in (Japan),
• Ampio pharmaceutical Inc. (US),
• Olain Farm (Lavtvia),
Get a Copy of Sample Report @ https://www.marketresearchfuture.com/sample_request/1547
GSK, has announced a new spray intranasal steroid fluticasone furoate for the treatment of allergic rhinitis in Philippines. Bureau of Food and Drugs, has approved nasal spray for the treatment of seasonal allergic rhinitis and perennial allergic rhinitis in adults and children with minimum age of two years. In 2014 company got FDA approval to launch Flonase, to be sold over the counter. This drug is used to treat temporary hay fever.
Johnson & Johnson, the company has a wide range of products which also includes medical products. The company recently has announced the launch of allergy spray named Rhinocort that is available over the counter. The Rhinocort will be sold over the counter all over America. The company is also the maker of a very well know product the Zyrtec.
Merck as well as the maker of various products for seasonal, perennial allergic rhinitis. Merck is collaborating with F-star to strengthen its immune-oncology portfolio. The F-star is a bio-pharmaceutical company in UK.
Another big brands that have a huge product variety for the allergic symptoms is The Himalayas Drug Company which is an Indian brand and has herbal products for various diseases. There are various players in US, Japan and China who are operating in the global allergic rhinitis market.
Taste the market data and market information presented in more than 50 market data tables and figures spread over 80 pages of the project report. Avail the in-depth table of content (TOC) & market synopsis on “Global Allergic Rhinitis Market” Research Report – Forecast till 2023.“
Report Details @ https://www.marketresearchfuture.com/reports/allergic-rhinitis-market-1547
Segmentation:
The market of allergic rhinitis is segmented into types by treatment and by test. The types of allergic rhinitis include seasonal, perennial and non-allergic rhinitis. On the basis of treatment the market is segmented into antihistamines, decongestants, eye drops, nasal sprays, immunotherapy, sublingual immunotherapy (SLIT), and home remedies. The antihistamine segment is further sub-segmented into drugs like Allegra, Clarinex, Xyzal and Zyrtec. The decongestants segment is also sub-segmented into afrin nasal spray, sudafed, sudafed PE and zyrtec-D. On the basis of test the segmentation is done into skin tests, IgE RAST test, and complete blood count.
Table of Content
1 Introduction
1.1 Definition
1.2 Scope Of Study
1.2.1 Research Objective
1.2.2 Assumptions & Limitations
1.2.2.1 Assumptions
1.2.2.2 Limitations
1.3 Market Structure:
2 Research Methodology
2.1 Research Process:
2.2 Primary Research
2.3 Secondary Research:
3 Market Dynamics
3.1 Drivers
3.2 Restraints
3.3 Opportunities
Continued….
Browse Related Statistical Report
Europe Clinical Reference Laboratory Market, is projected to grow at a CAGR of 5.4% and is expected to reach US$ 1,14,128.8 million by 2027. In Europe Clinical Reference Laboratory Market, Western Europe accounted for the largest market share in 2016.
Factors such as emerging markets, changing pharmaceutical ecosystem and cost pressures. Aging population and change in demographics further initiate the growth of clinical laboratory market in Europe. There is increasing laboratory outsourcing trends observed in France and Spain contributing of the market growth.
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
Contact Info:
Name: Akash Anand
Email: akash.anand@marketresearchfuture.com
Organization: Market Research Future
Address: Office No. 524/528, Amanora Chambers Magarpatta Road, Hadapsar Pune –
Phone: +1 646 845 9312
Source URL: http://marketersmedia.com/allergic-rhinitis-market-is-expected-to-grow-by-the-cagr-of-7-by-2023/210782
For more information, please visit https://www.marketresearchfuture.com/reports/allergic-rhinitis-market
Source: MarketersMedia
Release ID: 210782
Copyright © 1999-2013 SproutNews.com
